Evidence map›Paper›PMID 11401984›Full record

ArticleInfection and immunity2001

Cloning, overexpression, purification, and immunobiology of an 85-kilodalton outer membrane protein from Haemophilus ducreyi.

K L Thomas, I Leduc, B Olsen, C E Thomas, D W Cameron, C Elkins

Abstract read
In one paragraph

Article in Infection and immunity, 2001. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed.

  1. Review
  2. Cracking outer membrane biogenesis.Biochimica et biophysica acta. Molecular cell research · 2023
    Article
  3. Defining Potential Vaccine Targets of Haemophilus ducreyi Trimeric Autotransporter Adhesin DsrA.Monoclonal antibodies in immunodiagnosis and immunotherapy · 2015
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

K L ThomasDepartment of Medicine, School of Medicine, University of North Carolina, Chapel Hill, North Carolina 27599, USA.
I Leduc
B Olsen
C E Thomas
D W Cameron
C Elkins

Funding

Trichomonas Typing SystemU19AI031496 · NIAID · UNIV OF NORTH CAROLINA CHAPEL HILL · PI HOBBS, MARCIA METZGAR · 1995 to 2014
$24.9M
IMMUNOBIOLOGY OF HEMOGLOBIN/HEME RECEPTORS OF H DUCREYIR29AI040263 · NIAID · UNIVERSITY OF NORTH CAROLINA CHAPEL HILL · PI ELKINS, CHRISTOPHER · 1996 to 2000
$97k
THE EPIDEMIOLOGY OF STDS IN RURAL NORTH CAROLINAU01AI031496 · NIAID · UNIVERSITY OF NORTH CAROLINA CHAPEL HILL · PI CANNON, JANNE G · 1991 to 1994
–
NIAID NIH HHS AI31496NIAID NIH HHS R-29-AI40263NIAID NIH HHS U19 AI031496
6 · The paper itself

Abstract

We have identified an 85-kDa outer membrane protein that is expressed by all tested strains of Haemophilus ducreyi. Studies of related proteins from other pathogenic bacteria, including Haemophilus influenzae, Pasteurella multocida, Neisseria gonorrhoeae, Neisseria meningitidis, and Shigella dysenteriae, suggested a role for these proteins in pathogenesis and immunity. In keeping with the first such described protein from Haemophilus influenzae type B, we termed the H. ducreyi protein D15. The gene encoding the H. ducreyi D15 protein was cloned and sequenced, and the deduced amino acid sequence was found to be most similar to sequences of the D15-related proteins from other Pasteurella spp. The arrangement of the flanking genes was similar to that of H. influenzae Rd and suggested that D15 was part of a multigene operon. Attempts to make a null mutation of the D15 gene were unsuccessful, paralleling results in other D15 gene studies. Overexpression of H. ducreyi D15 in Escherichia coli resulted in a source of recombinant D15 (rD15) from which it was readily purified. rD15 was immunogenic, and it was found that immunization of rabbits with an rD15 vaccine preparation conferred partial protection against a virulent challenge infection. Antisera to an N-terminal peptide recognized all tested strains of H. ducreyi.

Indexed as

Amino Acid SequenceAnimalsAntibodies, BacterialBacterial Outer Membrane ProteinsBase SequenceCloning, MolecularDNA, BacterialEscherichia coliGene ExpressionHaemophilus ducreyiHistidineMolecular Sequence DataRabbitsRecombinant Fusion ProteinsSequence Analysis, DNASequence Homology, Amino AcidAntibodies, BacterialBacterial Outer Membrane Proteinsd15 protein, Haemophilus ducreyiDNA, BacterialHistidineRecombinant Fusion Proteins

Identifiers

PMID11401984
PMCPMC98517

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.